Vijay K. Lathi

Vijay K. Lathi has filed trades across 3 companies (mainly through SEC (Form 4)), most often in iRhythm Holdings, Inc., Iterum Therapeutics plc and SGX Pharmaceuticals, Inc. Between 6 February 2006 and 30 May 2018, the trades on record add up to 32 filings.

Both buying and selling appear: 4 purchases worth €8.3M, against 20 sales worth €70.0M. On balance, insiders were net sellers of €61.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. So far in 2018, the count stands at 2 purchases and 6 sales.

The median purchase comes to €1.8M.

Most recently, on 31 May 2018, the filings show a transaction in Iterum Therapeutics plc. The most recent open-market purchase was published on 31 May 2018, 3,084 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.